Since similar signaling deregulation can arise in different cancers (e.g. dysregulated PI3K/AKT/mTOR pathway in gynecologic cancer)48, further research on the link between shared molecular signatures within tumors in the same cluster could shade light on the development of novel therapies, or the repurpose and combination of existing ones. This evidence concerns the gene AKT1 and female reproductive organ cancer.